Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ChemoMetec A/S MAinatians FY 2012/2013 Financial Guidance


Wednesday, 27 Feb 2013 03:56am EST 

ChemoMetec A/S announced that it has maintained its fiscal year 2012/2013 financial guidance. The Company still expects to report fiscal year 2012/2013 revenue of approximately DKK 40 million and fiscal year 2012/2013 EBITDA in a range of between DKK 6 million and DKK 8 million which is corresponding to fiscal year 2012/2013 EBIT in a range of between DKK 0 and DKK 2 million. 

Company Quote

3.65
0.03 +0.83%
9:29am EDT